NDC 68071-4933-02 - Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-4933
- Requested NDC
- 68071-4933-02
- Package NDCs from labels
- 68071-4933-9, 68071-4933-7, 68071-4933-3, 68071-4933-2, 68071-4933-02
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2026-10-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrochlorothiazide Tablets, USP | NuCare Pharmaceuticals,Inc. | 2026-10-08 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-06-14 | Hydrochlorothiazide Tablets, USP |
| 2024-06-14 | Hydrochlorothiazide Tablets, USP |
| 2024-06-14 | Hydrochlorothiazide Tablets, USP |
| 2023-01-30 | Hydrochlorothiazide Tablets, USP |
| 2023-01-30 | Hydrochlorothiazide Tablets, USP |
| 2023-01-30 | Hydrochlorothiazide Tablets, USP |
| 2021-02-18 | Hydrochlorothiazide Tablets, USP |
| 2021-02-18 | Hydrochlorothiazide Tablets, USP |
| 2021-02-18 | Hydrochlorothiazide Tablets, USP |
| 2021-01-29 | Hydrochlorothiazide Tablets, USP |
| 2021-01-29 | Hydrochlorothiazide Tablets, USP |
| 2021-01-29 | Hydrochlorothiazide Tablets, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-4933-7 | Hydrochlorothiazide | 20 in 1 BOTTLE | TABLET | 20 | 4 | |
| 68071-4933-9 | Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET | 90 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-4933 | HYDROCHLOROTHIAZIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 4 | Current NDC, Legacy NDC, 2 package rows | 20240906_8bc8d5e2-a974-64ed-e053-2a95a90a8340.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 5fc69fbf-c2d2-41ef-99bb-62a76ef74db2 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 681dfb5c-fc5c-427e-81f6-4b4e934978a2 | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | REMEDYREPACK INC. | 3bea11a3-eb07-46b2-9b91-f8a48a2f3b7e | 2026-10-12 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 31a3d1cb-0f52-4818-965d-7584374bb23e | 2026-10-12 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Granules Pharmaceuticals Inc. | b4168479-09ec-402c-89cc-456bc8485017 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Advagen Pharma Ltd | f4b10352-a923-4713-9d33-8f3636941b2e | 2026-10-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 8bc8d5e2-a974-64ed-e053-2a95a90a8340 | 2026-10-08 | Warnings, Adverse reactions | ANDA040907 68071-4933-2 68071-4933-3 68071-4933-7 68071-4933-9 68071-4933 68071493302 310798 5d5a7128-2b05-614f-e063-6294a90ac5cd 8bc8d5e2-a974-64ed-e053-2a95a90a8340 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | St. Mary's Medical Park Pharmacy | 00b266d9-ac4a-e931-e063-6294a90a6a0b | 2026-10-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Westminster Pharmaceuticals, LLC | 0fc94bc2-fa38-439a-a609-1b4130cdacb1 | 2026-09-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Ascend Laboratories, LLC | 798fee33-51ad-45d0-82f3-09289304139f | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | b9b85048-5776-455f-bea6-6ab818cb8144 | 2026-09-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 2dd7c2a4-d335-4c6f-b1e6-b0ae6eebab84 | 2026-09-23 | Warnings, Adverse reactions | 429503 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | e92f1118-8eaf-4fa8-b167-1447550af1ab | 2026-09-18 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 2db1a899-f115-4da5-89fe-6e5b41086f6c | 2026-09-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | 5ba10848-9a4c-1a28-e063-6394a90ab047 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 5ba2325f-5fc1-f6f0-e063-6294a90aefc6 | 2026-09-16 | Warnings, Adverse reactions | 429503 0J48LPH2TH |
| Metoprolol Tartrate and Hydrochlorothiazide | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | b6cf0f43-8dc3-4535-b651-daf1f9e0336c | 2026-09-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | REMEDYREPACK INC. | d383e0e5-4e00-44cc-9d6f-86e76f4e79e3 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 206cd386-cf38-4e0f-80ec-685aea41b048 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.